Topics

US patent granted to UniQure for its FIX-Padua gene therapy

04:44 EST 8 Nov 2019 | SmartBrief

UniQure was granted a third patent by the US Patent and Trademark Office for its formulation and use of a factor IX Padua gen -More

Original Article: US patent granted to UniQure for its FIX-Padua gene therapy

NEXT ARTICLE

More From BioPortfolio on "US patent granted to UniQure for its FIX-Padua gene therapy"

Quick Search